Inj triamcinolone ace xr 1mg
Products billed under this code include Zilretta.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Zilretta.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Zilretta | Pacira Pharmaceuticals, Inc. | 65250-0003-01 | 32 | $613.088 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $19.159 | −$0.121 | 1 MG | Inj triamcinolone ace xr 1mg | v1, posted September 17, 2026 |
| 3Q26 | $19.28 | +$0.644 | 1 MG | Inj triamcinolone ace xr 1mg | v1, posted September 15, 2026 |
| 2Q26 | $18.636 | +$0.057 | 1 MG | Inj triamcinolone ace xr 1mg | v1, posted September 15, 2026 |
| 1Q26 | $18.579 | +$0.282 | 1 MG | Inj triamcinolone ace xr 1mg | v1, posted September 15, 2026 |
| 4Q25 | $18.297 | +$0.088 | 1 MG | Inj triamcinolone ace xr 1mg | v1, posted September 8, 2026 |
| 3Q25 | $18.209 | +$0.202 | 1 MG | Inj triamcinolone ace xr 1mg | v1, posted March 10, 2026 |
| 2Q25 | $18.007 | +$0.009 | 1 MG | Inj triamcinolone ace xr 1mg | v1, posted March 10, 2026 |
| 1Q25 | $17.998 | +$0.252 | 1 MG | Inj triamcinolone ace xr 1mg | v1, posted December 19, 2025 |
| 4Q24 | $17.746 | −$0.08 | 1 MG | Inj triamcinolone ace xr 1mg | v1, posted June 11, 2025 |
| 3Q24 | $17.826 | +$0.335 | 1 MG | Inj triamcinolone ace xr 1mg | v1, posted June 11, 2025 |
| 2Q24 | $17.491 | −$0.05 | 1 MG | Inj triamcinolone ace xr 1mg | v1, posted March 11, 2025 |
| 1Q24 | $17.541 | +$0.416 | 1 MG | Inj triamcinolone ace xr 1mg | v1, posted December 19, 2024 |
| 4Q23 | $17.125 | +$0.011 | 1 MG | Inj triamcinolone ace xr 1mg | v1, posted October 10, 2024 |
| 3Q23 | $17.114 | +$0.252 | 1 MG | Inj triamcinolone ace xr 1mg | v1, posted June 5, 2024 |
| 2Q23 | $16.862 | −$0.092 | 1 MG | Inj triamcinolone ace xr 1mg | v1, posted February 23, 2024 |
| 1Q23 | $16.954 | +$0.028 | 1 MG | Inj triamcinolone ace xr 1mg | v1, posted December 6, 2023 |
| 4Q22 | $16.926 | −$0.063 | 1 MG | Inj triamcinolone ace xr 1mg | v1, posted June 22, 2023 |
| 3Q22 | $16.989 | −$0.514 | 1 MG | Inj triamcinolone ace xr 1mg | v1, posted June 9, 2023 |
| 2Q22 | $17.503 | −$0.124 | 1 MG | Inj triamcinolone ace xr 1mg | v1, posted December 14, 2022 |
| 1Q22 | $17.627 | −$0.121 | 1 MG | Inj triamcinolone ace xr 1mg | v1, posted June 8, 2022 |
| 4Q21 | $17.748 | −$0.248 | 1 MG | Inj triamcinolone ace xr 1mg | v1, posted June 2, 2022 |
| 3Q21 | $17.996 | +$0.109 | 1 MG | Inj triamcinolone ace xr 1mg | v1, posted June 2, 2022 |
| 2Q21 | $17.887 | −$0.119 | 1 MG | Inj triamcinolone ace xr 1mg | v1, posted March 1, 2022 |
| 1Q21 | $18.006 | – | 1 MG | Inj triamcinolone ace xr 1mg | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.